chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cryptococcus test, Delusion, Drug screen negative, Electroencephalogram abnormal, Full blood count normal
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Grandiosity, Insomnia, Lymphocyte count decreased, Magnetic resonance imaging brain abnormal, Metabolic function test
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Monocyte count increased, Periventricular leukomalacia, Pressure of speech, Protein total increased, Psychotic symptom
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell count decreased, Speech disorder
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Injected limb mobility decreased, Injection site pain, Pain
Clinical narrative: The day after the shot the injection site and left arm were extremely sore, and it was very difficult to lift my arm. I have been having headaches and body aches. I have had trouble sleeping and wake up with soreness  and aching in my joints where I typically do not have soreness. Today, I am experiencing some soreness and muscle strength loss in the arm where I received the injection.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: The day after the shot the injection site and left arm were extremely sore, and it was very difficult to lift my arm. I have been having headaches and body aches. I have had trouble sleeping and wake up with soreness  and aching in my joints where I typically do not have soreness. Today, I am experiencing some soreness and muscle strength loss in the arm where I received the injection.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Periorbital oedema
Clinical narrative: The next day, developed mild peri-orbital edema. No other symptoms. It resolved in one week. He received the second dose in the series. The same thing happened.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Electrocardiogram
Clinical narrative: New onset Atrial Fibrillation
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pyrexia
Clinical narrative: Fever (99.9) Severe muscle and joint pain all over Exhaustion Moderate by 4 hours post injection Much more severe the first day after Moderate the second day after Gone by third day after
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Severe pain at injection site started 11 days after vaccination. Pain is constant even if not moving arm.  Minor pain after injection lasted about 2 days.
Age: 57.0
Sex: U
Vaccine: VARZOS
Symptoms: Bronchitis, Facial paralysis, Herpes zoster, Post herpetic neuralgia, Rash
Clinical narrative: facial paralysis; postherpetic neuralgia; bronchitis; painful rash, herpes zoster; Information has been received regarding a case in litigation from a lawyer referring to a currently approximately 63 years old patient of unknown gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 20-SEP-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) at a pharmacy for the long-term prevention of shingles and zoster-related conditions. Subsequently, the patient was treated by providers for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: painful rash, herpes zoster, postherpetic neuralgia, facial paralysis and bronchitis. The outcome of the events herpes zoster, postherpetic neuralgia, facial paralysis and bronchitis was unknown.  Upon internal review, facial paralysis was determined to be medically significant.
Sex: U
Vaccine: VARZOS
Symptoms: Muscular weakness, Pain in extremity
Clinical narrative: pain and weakness in the arm; weakness in the arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and weakness of arms. On an unknown date, the outcome of the pain in arm and weakness of arms were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and weakness of arms to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. The patient received Shingrix in an unknown arm. At the time of reporting, the patient was still feeling pain and weakness in the arm of injection.
Sex: U
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Fever; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrx, the patient experienced fever.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Erythema, Herpes zoster, Pain, Rash erythematous
Clinical narrative: Red spots started showing up, mainly on my back; Diagnosed with Shingles (Herpes Zoster) / confirmed my diagnosis; Feeling a burning sensation on my back and right side of my chest; Severe pain / some strong pain; today's blister stage; This case was reported by a consumer and described the occurrence of shingles in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th January 2021, the patient received Shingrix. In January 2021, less than a week after receiving Shingrix, the patient experienced pain and blister. On 20th January 2021, the patient experienced shingles and burning sensation. On 22nd January 2021, the patient experienced red spotty rash. The patient was treated with valaciclovir hydrochloride (Valacyclovir) and gabapentin (Neurontin (Gabapentin)). On an unknown date, the outcome of the shingles, burning sensation, red spotty rash, pain and blister were not recovered/not resolved.   It was unknown if the reporter considered the shingles, burning sensation, red spotty rash, pain and blister to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient himself. Two days after receiving Shingrix, the patient started feeling a burning sensation on his back and right side of his chest. The patient stated that 4 days after receiving Shingrix, the burning sensation had increased, and red spots started showing up, mainly on his back. On 22nd January 2021, in the morning, he got a response from his primary care physician and he was able to go to an appointment, where they confirmed his diagnosis of Herpes zoster without complication  and had BMI (body mass index) 36.0 to 36.9 and because the patient was in severe pain, he was prescribed with Neurontin (Gabapentin) (Drug Code 69097-0813-12) 100 mg (quantity 30) to take at bedtime and was advised to return in about 6 week for annual (next visit, around 5th March 2021) and was discussed to exercise 3x per week (30 min per time). On 22nd January 2021, blood pressure measurement result was 133/88 mm hg, body mass index result was 36.68, body temperature result was 98.1 degree F, heart rate result was 101 /min, oxygen saturation result was 96 percent and respiratory rate result was 18 /min. On 23rd January,2021, the patient's symptoms increased and in the early morning, the patient went and was diagnosed with Shingles (Herpes Zoster) and was prescribed with Valacyclovir (Drug Code 59746-0325-37) 1 gm tablets (quantity 21) to take 3 times a day for 7 days. The patient had provided the picture of reporting day blister stage. The patient stated that the results of receiving the vaccination had been a huge source of worry and had taken a significant toll in his life and he would like to know what steps we were able to take to make things right in this difficult situation.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Skin burning sensation
Clinical narrative: Red spots started showing up, mainly on my back; Diagnosed with Shingles (Herpes Zoster) / confirmed my diagnosis; Feeling a burning sensation on my back and right side of my chest; Severe pain / some strong pain; today's blister stage; This case was reported by a consumer and described the occurrence of shingles in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th January 2021, the patient received Shingrix. In January 2021, less than a week after receiving Shingrix, the patient experienced pain and blister. On 20th January 2021, the patient experienced shingles and burning sensation. On 22nd January 2021, the patient experienced red spotty rash. The patient was treated with valaciclovir hydrochloride (Valacyclovir) and gabapentin (Neurontin (Gabapentin)). On an unknown date, the outcome of the shingles, burning sensation, red spotty rash, pain and blister were not recovered/not resolved.   It was unknown if the reporter considered the shingles, burning sensation, red spotty rash, pain and blister to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient himself. Two days after receiving Shingrix, the patient started feeling a burning sensation on his back and right side of his chest. The patient stated that 4 days after receiving Shingrix, the burning sensation had increased, and red spots started showing up, mainly on his back. On 22nd January 2021, in the morning, he got a response from his primary care physician and he was able to go to an appointment, where they confirmed his diagnosis of Herpes zoster without complication  and had BMI (body mass index) 36.0 to 36.9 and because the patient was in severe pain, he was prescribed with Neurontin (Gabapentin) (Drug Code 69097-0813-12) 100 mg (quantity 30) to take at bedtime and was advised to return in about 6 week for annual (next visit, around 5th March 2021) and was discussed to exercise 3x per week (30 min per time). On 22nd January 2021, blood pressure measurement result was 133/88 mm hg, body mass index result was 36.68, body temperature result was 98.1 degree F, heart rate result was 101 /min, oxygen saturation result was 96 percent and respiratory rate result was 18 /min. On 23rd January,2021, the patient's symptoms increased and in the early morning, the patient went and was diagnosed with Shingles (Herpes Zoster) and was prescribed with Valacyclovir (Drug Code 59746-0325-37) 1 gm tablets (quantity 21) to take 3 times a day for 7 days. The patient had provided the picture of reporting day blister stage. The patient stated that the results of receiving the vaccination had been a huge source of worry and had taken a significant toll in his life and he would like to know what steps we were able to take to make things right in this difficult situation.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Injection site pain, Pain in extremity, Pyrexia
Clinical narrative: Chills; Fever; Pain in the arm of the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd August 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 6 months after receiving Shingrix, the patient experienced injection site pain, chills and fever. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the chills and fever were unknown.   It was unknown if the reporter considered the injection site pain, chills and fever to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The patient experienced pain in the arm of the injection site for one week, she did not recall which arm. The patient took Tylenol for the pain, and it was relieved. The patient also had fever and chills, she did not recall exactly when she experienced these symptoms.  The reporter did not consent to follow-up. All information was not available.  The consumer did not want to share her address.
Sex: U
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Swelling face, Throat tightness, Urticaria
Clinical narrative: Hives; facial swelling; felt throat closing; late phase reaction; This case was reported by a physician via call center representative and described the occurrence of hives in a patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2020-2021 season) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received FluLaval Tetra 2020-2021 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, immediately after receiving FluLaval Tetra 2020-2021 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced hives (serious criteria other: as per reporter), facial swelling (serious criteria other: as per reporter), throat constriction (serious criteria other: As per reporter) and delayed type hypersensitivity (serious criteria other: as per reporter). The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the hives, facial swelling and throat constriction were recovering/resolving and the outcome of the delayed type hypersensitivity was recovered/resolved.   It was unknown if the reporter considered the hives, facial swelling, throat constriction and delayed type hypersensitivity to be related to FluLaval Tetra 2020-2021 season and Flulaval Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: Age at vaccination was not reported. The patient experienced Immediate severe reaction as hives, facial swelling, felt throat closing. The patient was given 50 mg Benadryl and symptoms improved but the patient had a late phase reaction that clear with Benadryl. No adrenaline given. The reporter asked what are the ingredients in the Flulaval Quadrivalent season 2020-2021?  The reporter wanted to know if the vaccine contain Flulaval Q contain PEG or polysorbate? The reporter did not consent to follow-up. No additional information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received moderna vaccine; A spontaneous report received from a Consumer concerning, 16-year-old female patient who received Moderna COVID-19 vaccine /MedDRA PT: [Inappropriate Age].   The patient's medical history was not included/ unknown. Patient's concomitant was not included/ unknown.    On 13-JAN-2021, the patient received their first of two planned doses of mRNA-1273 in her left arm (Batch #: 012L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 10-FEB-2021 patient's mother stated that her 16-year-old daughter received the first dose of the Moderna COVID-19 vaccine. Mother stated that her daughter was scheduled to receive the second dose on 10Feb2021. The local health department denied patient the second dose and advised patient to reach out to the Moderna clinical trial so she could receive the second dose.  Treatment information was not provided/ unknown.   Action taken with mRNA-1273 in response to the event was not provided/unknown.   The outcome of the event was unknown/not reported.; Reporter's Comments: This case concerns a 16 year old female who received their first of two planned doses of mRNA-1273 (Lot number: 012L20A) intramuscularly for prophylaxis of COVID-19 infection. There were no reported adverse events associated with this event of  product administered to patient of inappropriate age.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old patient vaccinated; A spontaneous report was received from a consumer concerning a 16-year-old female patient who received both doses,  The patient's medical history was not provided.    Concomitant product use was not provided by the reporter.  On unknown date, the patient received their second of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.  The patient received both doses and is only 16-years old. She forgot when she got vaccinated.   Treatment information was not provided.   The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.   The outcome for the event was considered resolved.; Reporter's Comments: This case concerns a 16 year old female who received her second of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection. There were no reported adverse events associated with this event of  product administered to patient of inappropriate age who received both doses.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: speculation that a patient may have been administered a second dose subcutaneously; A spontaneous report was received from a pharmacist concerning a patient, who experienced an event of inappropriate route of vaccine administration.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  The patient received their first of two planned doses of mRNA-1273 (Batch number: not provided) on an unspecified date. On an unspecified date, the patient received their second dose of mRNA-1273 (Batch number: not provided) subcutaneously for the prophylaxis of COVID-19 infection.  On an unspecified date, the patient received the second dose of vaccine resulting in the event of inappropriate route of vaccine administration.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, inappropriate route of vaccine administration, was considered resolved.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot# unknown) after the second dose was administered with no associated AEs reported.
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: patient did not get the full 0.5 ml dose; Part come out between the needle and syringe; A spontaneous report  was received from a nurse concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and did not get the full 0.5 ml dose and part come out between the needle and syringe.  The patient's medical history was not provided. No concomitant medications were reported.  On 08 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 031M20a) intramuscularly for prophylaxis of COVID-19 infection. While receiving the vaccine, the nurse stated that part of it went into the patient's arm and part come out between the needle and syringe. The patient did not get the full 0.5 ml dose and the nurse couldn't guess how much he received.  Action taken with mRNA-1273 in response to the events was not provided.  The events did not get the full 0.5 ml dose and part come out between the needle and syringe were considered resolved on 08 Feb 2021.; Reporter's Comments: This report refers to a case of syringe issue and underdose with mRNA-1273 (Lot number: 031M20a) with no associated AEs.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Some of the vaccine came out and was not completely administered; The syringe and needle came apart; A spontaneous report was received by a pharmacist regarding a 35-year-old female patient who experienced the needle and syringe coming apart while administering vaccine/syringe connection issue and the dose was not completely administered/vaccine underdose.    The patient's medical history was not provided. No concomitant medications provided.   On 10 Feb 2021, the patient received the second of two planned doses of mRNA-1273 (Batch number: 010M20A Expiration date: 19 Jul 2021) administered intramuscularly into the arm for prophylaxis of COVID-19 infection.  The patient received the second injection on 10 Feb 2021 and the pharmacist reported that the needle and the syringe came apart and some of the vaccine came out and was not administered. They believe the patient got approximately half of a dose.   Treatment information was not provided.   Consent to contact was obtained.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, needle and the syringe came apart and some of the vaccine came out and was not administered, was considered resolved.; Reporter's Comments: This report refers to a case of vaccine underdose and syringe issue for mRNA-1273 (lot # 010M20A) with no associated AEs reported.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Unable to receive second dose within the extended dosing window of 42 days; A spontaneous report was received from a consumer concerning a female patient, of unknown age, who was administered Moderna's COVID-19 vaccine (mRNA-1273) and the patient would be unable to receive second dose within the extended dosing window of forty-two days/ inappropriate schedule of product administration.  The patient's medical history included a broken hip. No relevant concomitant medications were reported.  On 04 JAN 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   The patient was originally scheduled for her second Moderna COVID-19 vaccine on 02 FEB 2021. The patient was hospitalized due to a broken hip that occurred prior to receiving her first dose of the vaccine and has not been released to receive her second dose. The patient was kept at the hospital for a scheduled hip replacement on 16 FEB 2021 and will not be released to receive the second vaccine. The hospital would not allow a vaccination provider to administer at the hospital where she was staying and therefore would be unable to receive her second dose within the extended dosing window of forty-two days. No treatment information was provided.  Action taken with the second dose of mRNA-1273 in response to the event was unknown.  The outcome of event, would be unable to receive second dose within the extended dosing window of forty-two days was considered as resolved.; Reporter's Comments: This case concerns a female patient of unknown age who would be unable to receive second dose within the extended dosing window of forty-two days(inappropriate schedule of product administration )for mRNA-1273 vaccine. ( Lot # not available as vaccine is yet to be administered) .
Sex: U
Vaccine: FLUX
Symptoms: Pneumonia
Clinical narrative: Pneumonia; Initial information received on 15-Feb-2021 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional (reference number: US-SA-SAC20210218000391, other: SAC20210218000391).  This case involves a patient (gender and age not reported) who experienced pneumonia, after receiving INFLUENZA VACCINE.  Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious pneumonia (unknown latency) following the administration of INFLUENZA VACCINE.   This event was assessed as medically significant.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for the event.  Information on the batch number was requested.; Sender's Comments: This case concerns a patient (gender and age not reported) who experienced pneumonia after vaccination with INFLUENZA VACCINE. The time to onset is unknown. Further information regarding medical history, concurrent condition during vaccination, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Lymphadenopathy, Pruritus
Clinical narrative: Red itchy injection site, swollen nodes under right arm, itchy right arm pit
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site discomfort
Clinical narrative: Redness, soreness at the site of the smallpox vaccine scar. Smallpox was administered in childhood in the country. COVID vaccine injection site is about two inches away from the smallpox scar.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Muscle and joint pain Exhaustion Fever (101) Chills All began by 4 hours post injection and resolved by morning of 2nd day post injection
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Pain in extremity
Clinical narrative: significant arm pain x1 week at time of reporting
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: pain in armpit on left arm that extends into elbow
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Frequent bowel movements, Malaise
Clinical narrative: Aside from the usual chills arm pain aches and general malaise for 5 days  , I?ve had more frequent and looser stools and stomach cramping since the day of the vaccine .
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Aside from the usual chills arm pain aches and general malaise for 5 days  , I?ve had more frequent and looser stools and stomach cramping since the day of the vaccine .
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Diarrhoea, Malaise, Muscle spasms, Pain in extremity
Clinical narrative: Aside from the usual chills arm pain aches and general malaise for 5 days  , I?ve had more frequent and looser stools and stomach cramping since the day of the vaccine .
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: 9 days post injection Red raised hard rash around injection site 3+ inches in diameter Itchy
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pruritus, Rash, Skin lesion
Clinical narrative: Moderna COVID-19 Vaccine EUA  Rash near the injection area 1 week after receiving 1st dose of the vaccine.  Itchy and appears to be patchy/legions.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Fever, fatigue, nausea, and R arm pain (like a lot)
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Glossodynia, Lip haemorrhage, Lip pain
Clinical narrative: Fatigue swollen lips mouth and tongue sore lips bleeding chest burning   No treatment  Lasted one week
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Oral pain, Oropharyngeal pain
Clinical narrative: Fatigue swollen lips mouth and tongue sore lips bleeding chest burning   No treatment  Lasted one week
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Dyskinesia, Feeling abnormal
Clinical narrative: Light headed, not functioning in a normal manner, moving slow/ balance, mildly dizzy, and lack the feeling without well being and conscious control
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Rhinorrhoea, Upper-airway cough syndrome
Clinical narrative: Post nasal drip, runny nose, chest discomfort, cough. Began two days after injection. Improved after two days, but still have mild symptoms. No fever.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Myalgia
Clinical narrative: Headache, muscle ache, fatigue. labored breathing  but not severe enough to go to the Emergency Room.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pain in extremity
Clinical narrative: Researched Covid Arm --Pain and hard red spot about the size of a quarter -- faded after 3 days but return after 10 days when scratched or rubbed site, fading again
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Axillary mass, Axillary pain
Clinical narrative: As I washed up in the morning, about 8 a.m., I noticed my underarm was sore.  As I examined the area several times during the next couple of hours I noticed a lump.  The lump was moveable, but seemed about the size of a nickle.  It scared me even though it was not actually in my breast.  The doctor told me since it was moveable and felt smooth he thought it to be a reaction to the Covid vaccine, but ordered a mammogram.  I called for the mammogram and was told I could not have one until 4 weeks after the 2nd shot.  I have a mammogram scheduled 3/26/2021.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pain in extremity
Clinical narrative: after the first moderna vaccine on 12/24, i had pain in both legs that persisted for over a month.  i didn't think it was related to the vaccine.  then after i had the 2nd vaccine on 1/21, i developed very painful aching in both shoulders, arms, wrists, which has persisted and worsened, along with persistent fatigue.  i met (remotely) with my pcp.  lab tests were unremarkable.  she prescribed prednisone and the pain was much less during the day, but severe when I woke in the mornings.  I met with a rheumatologist who advised me to stay off prednisone for 10 days to allow further testing to r/o polymyalgia reumatica secondary to the vaccine.  Since stopping prednisone the pain in my shoulders, arms, wrists and hands has intensified, as has my fatigue.  i have no prior hx of pain, autoimmune or rhematolocal conditions.   I'm pretty stubborn, and have continued to work despite sxs.  I missed last Friday 2/19 because the pain was so severe.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: On 2.23.20321 began to note itchy hives over both arms. More concentrated at vaccine sites, legs and torso.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Skin warm
Clinical narrative: Itchy, hot rash developed on arms. 24 hours later rash progressed to chest, neck and lower face. Not located at injection site.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Arthralgia, Chills, Diarrhoea, Fatigue
Clinical narrative: Sore arm with moderate pain, felt tired, unusually severe joint and muscle pain, a bad headache, stomach pain, diarrhea, suspected fever, then few hours later, sweating, shivering (could not get warm) and insomnia as a result of the suspected fever/chills/sweating.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Feeling cold, Headache, Hyperhidrosis, Insomnia, Myalgia
Clinical narrative: Sore arm with moderate pain, felt tired, unusually severe joint and muscle pain, a bad headache, stomach pain, diarrhea, suspected fever, then few hours later, sweating, shivering (could not get warm) and insomnia as a result of the suspected fever/chills/sweating.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Sore arm with moderate pain, felt tired, unusually severe joint and muscle pain, a bad headache, stomach pain, diarrhea, suspected fever, then few hours later, sweating, shivering (could not get warm) and insomnia as a result of the suspected fever/chills/sweating.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: Sudden appearance of redness around injection site 10 days after the injection.  Not itchy
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Consciousness fluctuating, Dizziness, Dyspnoea, Electroencephalogram normal
Clinical narrative: Patient received his first dose of vaccine on 2/10 at 11:30am. (His 2nd is scheduled for 3/3) He started with sx ~13 hrs later - He started drifting out of consciousness, then had labored breathing through night rendering him unable to sleep. After getting up in the morning, his breathing was better but he felt lightheaded/weak through the day. By the next morning (Friday 2/12), he was so bad next morning that wife called 911 - He reports that he was there and then not there and was losing track of train of thought. He was taken to ER via EMS, where his HR was initially 15 - He was admitted to hospital - initially a temporary pacer was placed, then a permanent one on Monday, 2/22. He has had other episodes like this in past 13 mos. PCP referred him to neurologist and EENT. Neurology work-up, including MRI and 72 hr EEG were unremarkable, although he learned retrospectively that there was a time during EEG where HR was only 35. EENT found no auditory or other issues . *MD in ER told him that if issues were not neuro in nature, they were probably cardiac.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Memory impairment, Neurological examination, Sleep disorder
Clinical narrative: Patient received his first dose of vaccine on 2/10 at 11:30am. (His 2nd is scheduled for 3/3) He started with sx ~13 hrs later - He started drifting out of consciousness, then had labored breathing through night rendering him unable to sleep. After getting up in the morning, his breathing was better but he felt lightheaded/weak through the day. By the next morning (Friday 2/12), he was so bad next morning that wife called 911 - He reports that he was there and then not there and was losing track of train of thought. He was taken to ER via EMS, where his HR was initially 15 - He was admitted to hospital - initially a temporary pacer was placed, then a permanent one on Monday, 2/22. He has had other episodes like this in past 13 mos. PCP referred him to neurologist and EENT. Neurology work-up, including MRI and 72 hr EEG were unremarkable, although he learned retrospectively that there was a time during EEG where HR was only 35. EENT found no auditory or other issues . *MD in ER told him that if issues were not neuro in nature, they were probably cardiac.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Groin pain
Clinical narrative: strong groin pain made it difficult to stand erect.  pain is still present today although  not as severe.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature increased, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: About 8 hrs after shot my mind started feeling foggy and heavy head, i got nauseous and achy joints and having breathing problems. i was just sic. or like i had the flu or covid again. went on through the night. was up all night. my arm was just killing me. The next morning i was full on sick. the nausea was intense my temp throughout day was 99.6 and 99.9 . out of breath. That night i went to bed and woke up at midnight  and was drenched my hair was soaked Got up at showered. at the 3:30 woke up again totally drenched. yesterday i woke up and 6:00 am i was feeling better but still trouble breathing but everything else was gone. I was tired still. About 10:30 yesterday Everything was fine. I do still have a little trouble breathing but not as bad.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Hyperhidrosis, Influenza like illness, Insomnia, Nausea
Clinical narrative: About 8 hrs after shot my mind started feeling foggy and heavy head, i got nauseous and achy joints and having breathing problems. i was just sic. or like i had the flu or covid again. went on through the night. was up all night. my arm was just killing me. The next morning i was full on sick. the nausea was intense my temp throughout day was 99.6 and 99.9 . out of breath. That night i went to bed and woke up at midnight  and was drenched my hair was soaked Got up at showered. at the 3:30 woke up again totally drenched. yesterday i woke up and 6:00 am i was feeling better but still trouble breathing but everything else was gone. I was tired still. About 10:30 yesterday Everything was fine. I do still have a little trouble breathing but not as bad.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sleep disorder
Clinical narrative: About 8 hrs after shot my mind started feeling foggy and heavy head, i got nauseous and achy joints and having breathing problems. i was just sic. or like i had the flu or covid again. went on through the night. was up all night. my arm was just killing me. The next morning i was full on sick. the nausea was intense my temp throughout day was 99.6 and 99.9 . out of breath. That night i went to bed and woke up at midnight  and was drenched my hair was soaked Got up at showered. at the 3:30 woke up again totally drenched. yesterday i woke up and 6:00 am i was feeling better but still trouble breathing but everything else was gone. I was tired still. About 10:30 yesterday Everything was fine. I do still have a little trouble breathing but not as bad.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza virus test, Pain, SARS-CoV-2 test positive
Clinical narrative: Patient indicates that after 5 days after administration started feeling headaches, body aches. Test results indicate Positive to COVID-19.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cerebrovascular accident, Computerised tomogram, Hemiplegia, Magnetic resonance imaging
Clinical narrative: 8 days after vaccination - stroke/full right side of body paralyzed - clot buster drug at ER
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Paralysis, Ultrasound Doppler
Clinical narrative: 8 days after vaccination - stroke/full right side of body paralyzed - clot buster drug at ER
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on trunk. 13 and still profuse
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Oedema peripheral, Pain
Clinical narrative: approximately 24 hrs after shot in left arm, IM, Left armpit swelling, assume lymph nodes. Slightly painful. Pain went from a 4 out of 10 to a 2 in 24 hrs, to 0 after 48 hours. Armpit is still swollen now. Visually obvious but no pain.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site nodule, Injection site warmth
Clinical narrative: Reddened warm knot area on arm where injection was done. Still there 2 weeks later improving
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Day 2-3: fever, chills, body aches, joint and muscle pain, headache, nausea, fatigue and vomiting Day 4-5: felt completely fine Day 5-6: that evening, all of the same symptoms returned, including fever of 102 Day 7-9: felt completely fine Day 10-11: all symptoms returned, including fever of 101 Day 12: today, feel completely fine
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Day 2-3: fever, chills, body aches, joint and muscle pain, headache, nausea, fatigue and vomiting Day 4-5: felt completely fine Day 5-6: that evening, all of the same symptoms returned, including fever of 102 Day 7-9: felt completely fine Day 10-11: all symptoms returned, including fever of 101 Day 12: today, feel completely fine
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Injection site pruritus, Injection site warmth, Rash macular
Clinical narrative: Never even felt the shot No adverse effects - not even sore at the site Today (10 after receiving the shot) the arm has red blotches at the site, is itching, hot, there is a hard lump Otherwise I feel fine
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain, Pyrexia
Clinical narrative: Low grade fever (100 degrees) for 24 hours Pain at injection site for 48 hours Pain when lifting my left arm for 36 hours
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paralysis
Clinical narrative: Bells Palsey
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Adult failure to thrive, Asthenia, General physical health deterioration
Clinical narrative: Subsequent morning after vaccination, client was too weak to get out of bed (per wife).  He stayed in bed for 3 to 4 days , then wife called  PCP.  Client stayed in bed for a total of 3 weeks , and had  3 home visits from PCP.   Was admitted for rehabilitation on 2-13-2021.  for a diagnosis of  failure to thrive.  Client is still at this facility as of this date.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid increased, Blood test normal, Chills, Computerised tomogram normal, Dehydration
Clinical narrative: Aches, Extreme chills(Chattering Teeth), no strength in legs.Could not stand up.EMS took him to hospital at 6:30 PM 2/20/2021. Extremely dehydrated. He was discharged the next afternoon at4 PM. Diagnosis: Elevated lactic acid level and fever after COVID -19 vaccination.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Muscular weakness, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Aches, Extreme chills(Chattering Teeth), no strength in legs.Could not stand up.EMS took him to hospital at 6:30 PM 2/20/2021. Extremely dehydrated. He was discharged the next afternoon at4 PM. Diagnosis: Elevated lactic acid level and fever after COVID -19 vaccination.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Disorientation, Dizziness, Fall, Head injury
Clinical narrative: Patient received her Covid 19 Vaccination on 2-11-21.  I counselled her about side effects and asked her to wait 15 minutes.  She waited and as she was leaving she fell to the floor and hit her head.  The other patients around her said it looked like she slipped, but when speaking to her it seemed that she had become dizzy and fell.  I spoke with her after she fell, she did not loose conscienceness, but was disoriented.  She did know what day it was, who she was and where she was.  She said her head hurt and she could move all her limbs.  I asked the store director, to call for an ambulance.  I sit with her for a few minutes and talked to her, then asked store director to stay with her until the ambulance arrived.  They arrived and spoke with her and decided to transport her to the hospital.  Later that day, her sister in law came by and said she was doing fine and had been released.  The doctors indicated they thought she because dizzy due to dehydration
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Limb discomfort
Clinical narrative: UKNOWN BRAND OF VACCINE; lightheadedness and arm "heaviness" status post receiving the first COVID vaccine 30 minutes PTA.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Injection site erythema, Pyrexia
Clinical narrative: Extreme backache, fever, redness at injection site
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Brain natriuretic peptide increased, Computerised tomogram abdomen abnormal, Dyspnoea, Flank pain
Clinical narrative: 1st Dose vaccine 1/29/21;  Admitted to Hospital from ED 2/1/21-2/4/21 Dx PNA,  d/c'd home. ; 2nd dose vaccine 2/19/21; seen in ED 2/22/21 for SOA, congestion, N/V, and Left flank pain x 3 days; admitted to hospital from ED 2/22/21 Dx: 1. Epigastric pain  R10.13 789.06 2. Elevated brain natriuretic peptide (BNP) level  R79.89 790.99 3. Dyspnea, unspecified type  R06.00 786.09 4. Abnormal CT of the abdomen  R93.5 793.6 5. Hypomagnesemia  E83.42 275.2 6. Hypokalemia  E87.6 276.8 Currently still admitted to hospital at time of this report.
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypokalaemia, Hypomagnesaemia, Nausea, Pneumonia, Pulmonary amyloidosis
Clinical narrative: 1st Dose vaccine 1/29/21;  Admitted to Hospital from ED 2/1/21-2/4/21 Dx PNA,  d/c'd home. ; 2nd dose vaccine 2/19/21; seen in ED 2/22/21 for SOA, congestion, N/V, and Left flank pain x 3 days; admitted to hospital from ED 2/22/21 Dx: 1. Epigastric pain  R10.13 789.06 2. Elevated brain natriuretic peptide (BNP) level  R79.89 790.99 3. Dyspnea, unspecified type  R06.00 786.09 4. Abnormal CT of the abdomen  R93.5 793.6 5. Hypomagnesemia  E83.42 275.2 6. Hypokalemia  E87.6 276.8 Currently still admitted to hospital at time of this report.
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, Vomiting
Clinical narrative: 1st Dose vaccine 1/29/21;  Admitted to Hospital from ED 2/1/21-2/4/21 Dx PNA,  d/c'd home. ; 2nd dose vaccine 2/19/21; seen in ED 2/22/21 for SOA, congestion, N/V, and Left flank pain x 3 days; admitted to hospital from ED 2/22/21 Dx: 1. Epigastric pain  R10.13 789.06 2. Elevated brain natriuretic peptide (BNP) level  R79.89 790.99 3. Dyspnea, unspecified type  R06.00 786.09 4. Abnormal CT of the abdomen  R93.5 793.6 5. Hypomagnesemia  E83.42 275.2 6. Hypokalemia  E87.6 276.8 Currently still admitted to hospital at time of this report.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: Rash on vaccine site and neck
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under right armpit about the size of an egg.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Lethargy, Muscular weakness, Weight bearing difficulty
Clinical narrative: This was the second dose in the vaccine series. The patient reported doing well for the first dose. A few minutes after receiving her second dose, the patient started to complain of lightheadedness, lethargy, arm weakness. She reported she did have an anaphylactic reaction to the H1N1 vaccine . Patient reported about 10 minutes after she received the vaccine she was starting to feel better- less lightheaded and was gaining arm strength. She was moved to a chair and she could not support her weight.  EMS was called to the scene and she was transported to the ER.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis acneiform, Rash
Clinical narrative: Rash on both wrist area. Pimples on each armpit/breast area and left forearm.